Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jun Sung Hong, Miao Wang, Dong Ha Kim, Cortney R. VanHook, Trenette T. Clark Goings & Dexter R. Voisin. (2022) Subtypes of Bullying and Types of Substance Use among Urban African American Adolescents: Who Is Likely to Use What?. Social Work in Public Health 37:5, pages 484-498.
Read now
Read now
Harvey L. Nicholson$suffix/text()$suffix/text() & Khary K. Rigg. (2022) Prescription opioid misuse among Black and White older adults. Addiction Research & Theory 30:1, pages 25-32.
Read now
Read now
Harvey L. Nicholson Jr.Paris B. Wheeler. (2021) Prescription Drug Misuse among African Americans and Afro Caribbeans: Results from the National Survey of American Life. Substance Use & Misuse 56:7, pages 962-970.
Read now
Read now
Jan van Amsterdam, Johannes G. Ramaekers, Ton Nabben & Wim van den Brink. (2021) Use characteristics and harm potential of ecstasy in The Netherlands. Drugs: Education, Prevention and Policy 28:2, pages 107-117.
Read now
Read now
Fermín Fernández-Calderón, Claudio Vidal-Giné, Antonio J. Rojas-Tejada & Óscar M. Lozano-Rojas. (2020) Patterns of Simultaneous Polysubstance Use among Partygoers: Correlates and Differences in Adverse Acute Effects Experienced. Journal of Psychoactive Drugs 52:4, pages 344-356.
Read now
Read now
Khary K. Rigg & Alexandra Mills. (2020) Sexual Risk Behaviors among African Americans Who Use MDMA (Molly/Ecstasy): Implications for HIV Prevention. Social Work in Public Health 35:5, pages 282-292.
Read now
Read now
Belén Vera, Claudio Vidal Giné, Oscar Lozano & Fermín Fernández Calderón. (2020) Harm reduction behaviors among polysubstance users who consume ecstasy: can they reduce the negative consequences? An exploratory study. Drugs: Education, Prevention and Policy 27:1, pages 49-59.
Read now
Read now
Maryam Akhgari, Fatemeh Moradi$suffix/text()$suffix/text() & Parisa Ziarati. (2018) The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients. Journal of Psychoactive Drugs 50:5, pages 451-459.
Read now
Read now
Khary K. Rigg & Amanda Sharp. (2018) Deaths related to MDMA (ecstasy/molly): Prevalence, root causes, and harm reduction interventions. Journal of Substance Use 23:4, pages 345-352.
Read now
Read now
Articles from other publishers (13)
Gracie Brownell. 2023. Changing the Stigma of Mental Health Among African Americans. Changing the Stigma of Mental Health Among African Americans
252
282
.
Martha Charlotta de Jonge, Andrea Johanna Bukman, Tom ter Bogt, Simone Arianne Onrust & Marloes Kleinjan. (2023) What Do Young Adults Expect from the Recreational Use of Ecstasy (3,4-Methylenedioxymethamphetamine/Molly)? A Latent Class Analysis of a Convenience Sample of Dutch Young Adults. European Addiction Research 29:3, pages 231-240.
Crossref
Crossref
Kevin H. Yang, Wayne Kepner, Anamika Nijum, Benjamin H. Han & Joseph J. Palamar. (2023) Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Michelle L. Burbage, Rebecca A. Vidourek, Ya-Hsuan Lin & Keith A. King. (2022) Ecstasy Use among Youth: an Examination of Psychosocial Factors. International Journal of Mental Health and Addiction.
Crossref
Crossref
Nienke Liebregts, Rafaela Rigoni, Benjamin Petruželka, Miroslav Barták, Magdalena Rowicka, Heike Zurhold & Katrin Schiffer. (2022) Different phases of ATS use call for different interventions: a large qualitative study in Europe. Harm Reduction Journal 19:1.
Crossref
Crossref
Lukas A. Basedow & Sören Kuitunen‐Paul. (2022) Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review 41:6, pages 1391-1403.
Crossref
Crossref
Terence HW Ching, Monnica T Williams, Julie B Wang, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson & Rick Doblin. (2022) MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial. Journal of Psychopharmacology 36:8, pages 974-986.
Crossref
Crossref
Zoe W. Jahn, Joel Lopez, Sara de la Salle, Sonya Faber & Monnica T. Williams. (2021) Racial/ethnic differences in prevalence of hallucinogen use by age cohort: Findings from the 2018 National Survey on Drug Use and Health. Journal of Psychedelic Studies 5:2, pages 69-82.
Crossref
Crossref
Monnica T. Williams, Sara Reed & Jamilah George. (2021) Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies 4:3, pages 125-138.
Crossref
Crossref
Logan Neitzke-Spruill. (2019) Race as a component of set and setting: How experiences of race can influence psychedelic experiences. Journal of Psychedelic Studies 4:1, pages 51-60.
Crossref
Crossref
Terence H. W. Ching. (2019) Intersectional insights from an MDMA-assisted psychotherapy training trial: An open letter to racial/ethnic and sexual/gender minorities. Journal of Psychedelic Studies 4:1, pages 61-68.
Crossref
Crossref
Jamilah R. George, Timothy I. Michaels, Jae Sevelius & Monnica T. Williams. (2019) The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies 4:1, pages 4-15.
Crossref
Crossref
Khary K. Rigg & Amanda Sharp. (2018) Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction. Addictive Behaviors 79, pages 159-165.
Crossref
Crossref